Market Report: Shire perks up on AstraZeneca buzz
Linkedin

Market Report: Shire perks up on AstraZeneca buzz

Shanghai : China | Jan 16, 2013 at 4:13 PM PST
Source: The Independent
XX XX
Views: Pending
 
Rare diseases are Shire's bag and it is this expertise in life-threatening genetic illnesses that has caught the eye of rival AstraZeneca well that is what traders would have us believe anyway. Shares in the drug maker Shire perked up 49p to 2,082p today as the rumour circulated that a potential bid could... FULL ARTICLE AT The Independent
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.